A Clinical Study to Assess the Efficacy of Chandraprabha Vati in Mutravaha Srotas Disorders
Vidyapharma Peer Reviewed Journal for Pharmaceutical Chemical Sciences and Ayurveda · 01.04.2026 · 144
DOI: 10.64522/v3i4.25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vidyapharma Peer Reviewed Journal for Pharmaceutical Chemical Sciences and Ayurveda, online erschienen am 01.04.2026. Verfasst von Dr. Kedar Deshmukh und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction – Disorders of the Mutravaha Srotas represent a frequently encountered category of conditions in clinical Ayurvedic practice. Patients typically present with a constellation of urinary complaints including dysuria, burning micturition, urgency, and increased frequency of urination. According to Ayurvedic pathophysiology, these manifestations arise primarily from the vitiation of Vata and Pitta Dosha, which disrupts the normal physiological functioning of the urinary channels. Chandraprabha Vati, a well-established classical herbo-mineral formulation, holds a prominent place in the management of such conditions owing to its documented Mutrala (diuretic), Shothahara (anti-inflammatory), and Vatanulomana (Vata-regulating) properties. Methods – This open-label clinical study enrolled 30 patients who met the diagnostic criteria for Mutravaha Srotas disorders. Participants received Chandraprabha Vati at a dose of 500 mg orally, twice daily, over a treatment period of 30 days. Clinical outcomes were evaluated through a structured symptom grading scale, and the data were analyzed statistically using the paired t-test. Results – Treatment with Chandraprabha Vati yielded statistically significant improvements across the primary symptom parameters, including burning micturition, dysuria, and urinary frequency. A marked reduction in mean symptom scores was recorded, with results reaching a high level of statistical significance (P < 0.001). Throughout the study period, no adverse effects were reported by any participant. Discussion: The therapeutic outcomes observed in this study are consistent with the classical Ayurvedic understanding of Mutravaha Srotas pathology. Chandraprabha Vati appears to exert its clinical effect principally through the correction of Apana Vata dysfunction a key etiological factor underlying urinary disorders while simultaneously mitigating Pitta-mediated inflammation within the urinary tract. These findings lend empirical support to the classical indications of this formulation and reinforce the relevance of traditional Ayurvedic principles in the contemporary clinical management of urinary channel disorders.
Zitieren
APA
Deshmukh, D. K., & Patil, D. R. (2026). A Clinical Study to Assess the Efficacy of Chandraprabha Vati in Mutravaha Srotas Disorders. Vidyapharma Peer Reviewed Journal for Pharmaceutical Chemical Sciences and Ayurveda, 144. https://doi.org/10.64522/v3i4.25
Vancouver
Deshmukh DK, Patil DR. A Clinical Study to Assess the Efficacy of Chandraprabha Vati in Mutravaha Srotas Disorders. Vidyapharma Peer Reviewed Journal for Pharmaceutical Chemical Sciences and Ayurveda. 2026:144. doi:10.64522/v3i4.25
BibTeX
@article{Deshmukh2026,
author = {Deshmukh, Dr. Kedar and Patil, Dr. Rohan},
title = {A Clinical Study to Assess the Efficacy of Chandraprabha Vati in Mutravaha Srotas Disorders},
journal = {Vidyapharma Peer Reviewed Journal for Pharmaceutical Chemical Sciences and Ayurveda},
year = {2026},
pages = {144},
doi = {10.64522/v3i4.25}
}
EUVIMED